Vincent de Caprio
Direttore/Membro del Consiglio presso New Jersey Institute of Technology
Profilo
Vincent de Caprio was President and Chief Executive Officer of Vyteris Holdings, Inc. He joined Vyteris Holdings, Inc. in 2000.
He is a Fellow of the American Institute of Medical and Biological Engineering.
He is a Trustee of New Jersey Institute of Technology.
He received a BSEE degree from the Newark College of Engineering in 1972, an MS degree in 1975 from Polytechnic University and a PhD in 1977 from Polytechnic University.
Posizioni attive di Vincent de Caprio
Società | Posizione | Inizio |
---|---|---|
New Jersey Institute of Technology | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Vincent de Caprio
Società | Posizione | Fine |
---|---|---|
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Presidente | 31/12/2005 |
Treasure Mountain Holdings, Inc. | Presidente | 17/05/2005 |
Formazione di Vincent de Caprio
New Jersey Institute of Technology | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Treasure Mountain Holdings, Inc. | Producer Manufacturing |
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Health Technology |
Polytechnic University | Consumer Services |
- Borsa valori
- Insiders
- Vincent de Caprio